Supporting Everyone, Not Just a Select Few Not every employee is eligible for, interested in, or covered for GLP-1s
10.3390/foods9030371 Foods
( 10.2337/dc12-2709) [DOI] [PMC free article] [PubMed] [Google Scholar] 98.Buse JB, Rosenstock J, Sesti G, Schmidt WE, Montanya E, Brett JH, Zychma M, Blonde L
Many clients using NAD injections regularly report: Better energy levels throughout the day Sharper concentration and faster cognitive processing Improved mood and emotional stability Enhanced workout recovery and physical performance More restful and refreshing sleep These effects build over time, with consistency playing a key role
Its also important to distinguish between normal, manageable side effects and more serious ones
Position in Therapy and Comparisons Comparison With Approved Dual Agonist: Tirzepatide Tirzepatide (Mounjaro for T2D, Zepbound for obesity) is a GLP-1R/GIPR dual agonist approved by the FDA in May 2022 and November 2023 respectively [15]